Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency
- PMID: 24792875
- DOI: 10.1016/j.jaci.2014.03.017
Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency
Abstract
Background: Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by B-cell dysfunction and, in a subgroup, by expansion of CD21(low) B cells. The CD21(low) B cells display defects in early B-cell receptor (BCR) signaling resembling those of anergic B cells.
Objective: We sought to investigate whether B cells from patients with CVID, like anergic B cells, have defects in extracellular signal-regulated kinase (ERK) phosphorylation and in endocytic trafficking of the BCR.
Methods: Using flow cytometry, we evaluated phosphorylated ERK (pERK) expression and internalization of cross-linked BCR in B-cell subsets. The localization of internalized BCR to lysosome-associated membrane protein 1-positive late endosomes was evaluated with confocal microscopy.
Results: Constitutive pERK levels were increased in naive and IgM(+) memory B cells of patients with CVID compared with those of healthy donors, whereas the pERK increment induced by BCR cross-linking was relatively reduced. Intravenous immunoglobulin administration enhanced these anomalies, but they appeared to be intrinsic to B cells from patients with CVID. Cross-linking-induced BCR endocytosis was decreased in the IgM(+) memory B cells, especially in those with a CD21(low) phenotype, but not in the naive B cells of patients with CVID with CD21(low) expansion. Internalized BCR localized normally to late endosomes. Pharmacologic inhibition of ERK phosphorylation suppressed BCR endocytosis in B cells of healthy patients and those with CVID.
Conclusions: The B cells of patients with CVID with CD21(low) B-cell expansion resemble anergic B cells based on high constitutive pERK expression. The IgM(+) memory B cells of these patients, especially those that are CD21(low), have a defect in BCR endocytosis seemingly caused by dysregulated ERK signaling.
Keywords: B-cell receptor; Common variable immunodeficiency; endocytosis; extracellular signal-regulated kinase.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiency.J Allergy Clin Immunol. 2017 Jan;139(1):220-231.e8. doi: 10.1016/j.jaci.2016.04.043. Epub 2016 Jun 14. J Allergy Clin Immunol. 2017. PMID: 27461466
-
B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency.J Immunol. 2010 Jun 15;184(12):7305-13. doi: 10.4049/jimmunol.1000434. Epub 2010 May 21. J Immunol. 2010. PMID: 20495065
-
Characterization of lymphocyte subsets in patients with common variable immunodeficiency reveals subsets of naive human B cells marked by CD24 expression.J Immunol. 2010 Dec 1;185(11):6431-8. doi: 10.4049/jimmunol.0903876. Epub 2010 Nov 1. J Immunol. 2010. PMID: 21041728
-
Common variable immune deficiency (CVID) presenting as an autoimmune disease: role of memory B cells.Autoimmun Rev. 2008 Feb;7(4):309-12. doi: 10.1016/j.autrev.2007.11.024. Epub 2007 Dec 31. Autoimmun Rev. 2008. PMID: 18295735 Review.
-
B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutations.Crit Rev Immunol. 2011;31(2):85-98. doi: 10.1615/critrevimmunol.v31.i2.10. Crit Rev Immunol. 2011. PMID: 21542788 Review.
Cited by
-
Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI.Front Immunol. 2022 Aug 16;13:938240. doi: 10.3389/fimmu.2022.938240. eCollection 2022. Front Immunol. 2022. PMID: 36072607 Free PMC article.
-
Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease.J Clin Immunol. 2023 Aug;43(6):1311-1325. doi: 10.1007/s10875-023-01485-9. Epub 2023 Apr 24. J Clin Immunol. 2023. PMID: 37093407 Free PMC article.
-
Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.Immunol Res. 2014 Dec;60(2-3):330-8. doi: 10.1007/s12026-014-8599-8. Immunol Res. 2014. PMID: 25407649
-
Intravenous Immunoglobulin and Immunomodulation of B-Cell - in vitro and in vivo Effects.Front Immunol. 2015 Jan 22;6:4. doi: 10.3389/fimmu.2015.00004. eCollection 2015. Front Immunol. 2015. PMID: 25657650 Free PMC article. Review.
-
Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren's Syndrome: Clues for a Personalized Medicine.Front Immunol. 2021 Jul 12;12:703780. doi: 10.3389/fimmu.2021.703780. eCollection 2021. Front Immunol. 2021. PMID: 34322134 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous